HERA

Jan 02 2025HEALTH

The Layout of Liver Cancer-Fighting Cells Matters

Cytotoxic T lymphocytes (CTLs) are crucial for fighting cancer, but many people with liver cancer (HCC) who have lots of these cells still face early relapse or resistance to treatments. Scientists don't fully understand why this happens. They studied 20 patients with liver cancer and CTLs to figure

reading time less than a minute
Jan 02 2025HEALTH

Plant Power: A New Way to Fix Genes

Scientists are finding an unexpected hero in the fight against cancer and inflammation: plants. They've discovered tiny bubbles made by plants, called PDNVs, that can safely carry important genetic messages to the right cells. These messages can help cells fix broken genes or fight diseases, making

reading time less than a minute
Jan 02 2025HEALTH

Reducing Surgery in Breast Cancer Patients: A New Approach

You might be wondering how breast cancer treatment is evolving. One big change is how doctors handle the lymph nodes under the arms. In the past, removing a bunch of these nodes after chemo was standard. But now, research shows that this might not always be necessary. Imagine this: a patient gets c

reading time less than a minute
Jan 02 2025HEALTH

Graphene: A New Hope in Cancer Treatment?

Cancer treatment is getting smarter by using several methods at once. One exciting tool is graphene-based nanomaterials (GBNs). These tiny powerhouses can do three amazing things: deliver drugs, fix faulty genes, and cook cancer cells with heat. That's multitasking at its best! Graphene, graphene o

reading time less than a minute
Jan 02 2025HEALTH

The Role of Physical Activity in Physiotherapy Training

These days, people aren't moving as much as they should. This inactivity is a big problem, and it's something that physiotherapists-in-training need to address. Physical activity is crucial for keeping our bodies healthy and strong. So, it makes sense that those who help others stay active should be

reading time less than a minute
Jan 02 2025HEALTH

Rethinking Recurrence: PIK3CA Mutations in HR+, HER2- Breast Cancer

Early-stage breast cancer patients with hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-) tumors face a big challenge: disease recurrence. This kind of cancer is diverse and tricky to manage because a quarter of these patients will see their disease come b

reading time less than a minute
Jan 02 2025HEALTH

Boosting Immunotherapy After Neoadjuvant Treatment for Esophageal Cancer: A Closer Look

Immunotherapy has been making waves in the treatment of esophageal cancer, especially when used after initial chemoradiation. But what about patients with esophageal squamous cell carcinoma who've had a different combo—immunochemotherapy before surgery? Does adjuvant immunotherapy (AIT) still matter

reading time less than a minute
Jan 01 2025HEALTH

Uncovering the Hidden Benefits of Regularly Visiting a Physical Therapist

Physical therapy isn't just for recovery after surgery or injury. It's also about prevention and maintaining good health. Sharon Dunn, a former president of the American Physical Therapy Association, says it's "the best-kept secret in health care. " Many people think physical therapists only help y

reading time less than a minute
Jan 01 2025HEALTH

How Letters Help in Group Therapy Sessions

Ever imagined using letters to heal? That’s exactly what happens in group schema therapy. This type of therapy mixes ideas from different fields to help patients in a unique way. One of the cool tools they use is therapeutic letters. You might think, “What can a letter do for therapy? ” Well, these

reading time less than a minute
Dec 31 2024HEALTH

Tislelizumab and Chemo: A Cost-Effective Pair for Advanced Stomach Cancer in China

Imagine you're a healthcare provider in China, trying to figure out the best treatment for advanced stomach cancer. A recent study, RATIONALE-305, found that combining a drug called tislelizumab with chemo works better than chemo alone. Now, researchers wanted to know if this combo is worth the extr

reading time less than a minute